Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use
Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose Use
复制标题
血管紧张素 II 1 型和 2 型受体调节基底骨骼肌微血管容量和葡萄糖使用
DOI:
10.1161/hypertensionaha.109.145409
复制
发表时间:
2010-02-01
期刊:
影响因子:
8.3
通讯作者:
Liu, Zhenqi
中科院分区:
文献类型:
--
作者:
Chai, Weidong;Wang, Wenhui;Liu, Zhenqi
Angiotensin II causes vasoconstriction via the type 1 receptor (AT1R) and vasodilatation through the type 2 receptor (AT2R). Both are expressed in muscle microvasculature, where substrate exchanges occur. Whether they modulate basal muscle microvascular perfusion and substrate metabolism is not known. We measured microvascular blood volume (MBV), a measure of microvascular surface area and perfusion, in rats during systemic infusion of angiotensin II at either 1 or 100 ng/kg per minute. Each caused a significant increase in muscle MBV. Likewise, administration of the AT1R blocker losartan increased muscle MBV by >3-fold (P<0.001). Hindleg glucose extraction and muscle interstitial oxygen saturation simultaneously increased by 2- to 3-fold. By contrast, infusing AT2R antagonist PD123319 significantly decreased muscle MBV by ≥80% (P<0.001). This was associated with a significant decrease in hindleg glucose extraction and muscle oxygen saturation. AT2R antagonism and inhibition of NO synthase each blocked the losartan-induced increase in muscle MBV and glucose uptake. In conclusion, angiotensin II acts on both AT1R and AT2R to regulate basal muscle microvascular perfusion. Basal AT1R tone restricts muscle MBV and glucose extraction, whereas basal AT2R activity increases muscle MBV and glucose uptake. Pharmacological manipulation of the balance of AT1R and AT2R activity affords the potential to improve glucose metabolism.